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AbstrAct
Objective
To examine the association of consumption of dairy 
foods with risk of total and cause specific mortality in 
women and men.
Design
Three prospective cohort studies with repeated 
measures of diet and lifestyle factors.
setting
Nurses’ Health Study, Nurses’ Health Study II, and the 
Health Professionals Follow-up Study, in the United 
States.
ParticiPants
168 153 women and 49 602 men without 
cardiovascular disease or cancer at baseline.
Main OutcOMe Measure
Death confirmed by state vital records, the national 
death index, or reported by families and the 
postal system. During up to 32 years of follow-up, 
51 438 deaths were documented, including 12 143 
cardiovascular deaths and 15 120 cancer deaths. 
Multivariable analysis further adjusted for family 
history of cardiovascular disease and cancer, physical 
activity, overall dietary pattern (alternate healthy 
eating index 2010), total energy intake, smoking 
status, alcohol consumption, menopausal status 
(women only), and postmenopausal hormone use 
(women only).
results
Compared to the lowest category of total dairy 
consumption (average 0.8 servings/day), the 
multivariate pooled hazard ratio for total mortality 
was 0.98 (95% confidence interval 0.96 to 1.01) for 
the second category of dairy consumption (average 
1.5 servings/day), 1.00 (0.97 to 1.03) for the third 
(average 2.0 servings/day), 1.02 (0.99 to 1.05) for 
the fourth (average 2.8 servings/day), and 1.07 (1.04 
to 1.10) for highest category (average 4.2 servings/
day; P for trend <0.001). For the highest compared to 
the lowest category of total dairy consumption, the 
hazard ratio was 1.02 (0.95 to 1.08) for cardiovascular 
mortality and 1.05 (0.99 to 1.11) for cancer mortality. 
For subtypes of dairy products, whole milk intake 
was significantly associated with higher risks of total 
mortality (hazard ratio per 0.5 additional serving/day 
1.11, 1.09 to 1.14), cardiovascular mortality (1.09, 
1.03 to 1.15), and cancer mortality (1.11, 1.06 to 
1.17). In food substitution analyses, consumption 
of nuts, legumes, or whole grains instead of dairy 
foods was associated with a lower mortality, whereas 
consumption of red and processed meat instead of 
dairy foods was associated with higher mortality.
cOnclusiOn
These data from large cohorts do not support an 
inverse association between high amount of total 
dairy consumption and risk of mortality. The health 
effects of dairy could depend on the comparison 
foods used to replace dairy. Slightly higher cancer 
mortality was non-significantly associated with dairy 
consumption, but warrants further investigation.
Introduction
Dairy products are widely consumed worldwide. 
They are important sources of protein, vitamin D, and 
calcium, but several constituents of dairy foods such 
as saturated fat and cholesterol might have adverse 
effects on health. Previous observational studies have 
examined associations of dairy foods with multiple 
health outcomes. In general, the associations between 
total dairy and risk of hypertension,1 2 type 2 diabetes,3 
cardiovascular disease,4 colorectal cancer,5 and breast 
cancer6 were null or moderately inverse. However, 
higher intakes of dairy products have also been asso­
ciated with greater risk of prostate cancer7 and ovarian 
cancer.8 9
The results have also been inconsistent in pros­
pective observational studies of dairy intake and 
mortality: positive associations have been seen in 
some studies,10­12 while inverse or null associations 
have been seen in others.13­17 In two meta­analyses 
summarizing these findings, overall dairy intake was 
not significantly associated with risk of mortality 
but the heterogeneity between studies was high.18 19 
Reasons for the heterogeneity across studies included 
limited sample size in some studies, different types of 
dairy products, different overall dietary patterns across 
populations, and inconsistent control for confounding 
variables.
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WhAt Is AlreAdy knoWn on thIs topIc
The relation between dairy intake and various health outcomes including type 2 
diabetes, cardiovascular disease, and cancer have been extensively examined, 
and most studies have shown no appreciable beneficial or adverse associations
However, evidence on the association between dairy intake and mortality from 
prospective cohort studies is more limited
WhAt thIs study Adds
Total dairy intake was not associated with lower risk of total mortality
The health effects of dairy could depend on the comparison foods used to 
replace dairy
Slightly higher cancer mortality was non-significantly associated with dairy 
consumption, but warrants further investigation
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Therefore, we examined the association of total dairy 
consumption and dairy subtypes with total and cause 
specific mortality in three large cohorts, including the 
Nurses’ Health Study (NHS), Nurses’ Health Study II 
(NHSII), and Health Professional Follow­up Study 
(HPFS). The total sample size of our study was 217 755, 




The NHS began in 1976, when 121 700 female 
registered nurses aged 30­55 residing in 11 US states 
were recruited to complete a baseline questionnaire 
about their lifestyle and medical history. The NHSII was 
established in 1989 and consisted of 116 671 younger 
female registered nurses, aged 25­42 at baseline. The 
nurses responded to a baseline questionnaire similar 
to the NHS. The HPFS was initiated in 1986, and 
was composed of 51 529 male dentists, pharmacists, 
veterinarians, optometrists, osteopathic physicians, 
and podiatrists, aged 40­75 at baseline. Participants 
returned a baseline questionnaire about detailed 
medical history, lifestyle, and usual diet. Detailed 
descriptions of the three cohorts are provided 
elsewhere.20­22 In all the three cohorts, questionnaire 
data were collected at baseline and biennially 
thereafter, to update information on lifestyle factors 
and the occurrence of chronic diseases. These cohorts 
consist of participants with about 95% European 
ancestry. We excluded participants who reported 
cardiovascular disease or cancer at baseline for these 
analyses (1984 for the NHS, 1989 for the NHSII, and 
1986 for the HPFS).23 We further excluded participants 
with extreme and implausible daily energy intakes 
(<500 or >3500 kcal for women; <800 or >4200 kcal for 
men; 1 kcal=4.18 kJ=0.00418 MJ). The study protocol 
was approved by the institutional review boards of the 
Brigham and Women’s Hospital and Harvard T H Chan 
School of Public Health, and those of participating 
registries as required.
assessment of dairy consumption
In 1984, a 116 item food frequency questionnaire 
was administered to the NHS participants to obtain 
information on usual intake of food and beverages. 
Starting in 1986, an expanded 131 item food 
frequency questionnaire was administered every four 
years to update diet. Using a similar food frequency 
questionnaire, dietary data was collected every four 
years from the HPFS participants starting in 1986 
and from the NHSII participants starting in 1989. In 
all food frequency questionnaires, participants were 
asked how often (in nine categories, ranging from 
“never or less than once per month” to “six or more 
times per day”), on average, they consumed a standard 
portion size of each food item during the previous year. 
The questionnaire items for dairy products included 
“skim/low fat milk,” “whole milk,” “ice cream,” 
“sherbert,” “yogurt,” “cottage/ricotta cheese,” “cream 
cheese,” “other cheese,” and “cream.” The standard 
serving sizes were a 240 mL glass for skim/low fat milk 
and whole milk; one tablespoon (6 g) for cream; 1/2 
cup (120 mL) for sherbet or frozen yogurt, ice cream, 
and cottage and ricotta cheese; and 30 mL for cream 
cheese and other cheese. Butter consumption was 
not included because it is nutritionally distinct from 
other dairy foods. Consumption of total dairy foods 
was calculated as the sum of intakes of all types of 
dairy products. We further divided the individual 
dairy foods into four groups: milk, cheese, yogurt, and 
other types of dairy foods including ice cream, cream, 
and sherbert. The validity and reproducibility of the 
food frequency questionnaire have been described in 
detail elsewhere.24­27 Briefly, correlation coefficients 
comparing intakes based on four dietary records, each 
record lasting one week, collected over a one year 
period with a single food frequency questionnaire 
ranged from 0.57 for hard cheese to 0.97 for yogurt.26
assessment of covariates and effect modifiers
Updated information on age, weight, smoking status, 
physical activity, family history of cardiovascular 
disease and cancer, self reported diagnosis of diseases 
(including hypertension, hypercholesterolemia, 
cardiovascular disease, and cancer), and cardiovascular 
drug treatment use (including aspirin, diuretics, 
calcium blockers, β blockers, other antihypertensive 
drugs, statins, and other cholesterol lowering drugs) 
was collected in the biennial follow­up questionnaires 
in the NHS, NHSII, and HPFS. For female participants, 
we also ascertained data on menopausal status and 
postmenopausal hormone use. To measure the overall 
diet quality using food frequency questionnaire data, 
we calculated the alternate healthy eating index in the 
three cohorts.28
assessment of deaths
Our primary endpoint was death from any cause 
ascertained by 31 December 2016. In the NHS, NHSII, 
and HPFS, we performed systematic searches of state 
vital records and the national death index. This search 
was supplemented by reports from family members 
and postal authorities. Using these methods, we were 
able to ascertain more than 98% of the deaths in each 
cohort.29 Physicians who were blinded to data on dairy 
consumption and other risk factors reviewed death 
certificates and medical records to classify the cause 
of death according to ICD­8 and ICD­9 (international 
classification of diseases, 8th and 9th revisions).
statistical analysis
We followed the participants from the date of the 
return of the baseline questionnaire until their date 
of death or the end of follow­up (31 December 2016), 
whichever came first. We used Cox proportional haz­
ards regression models to examine the associations 
between total dairy consumption and risk of mortality. 
The regression models included follow­up time as 
the time scale and were stratified by age in years. In 
the multivariable analysis, we further adjusted for 
family history of cardiovascular disease and cancer, 
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physical activity, overall dietary pattern (alternate 
healthy eating index 2010), total energy intake, 
smoking status, alcohol consumption, menopausal 
status (women only), and postmenopausal hormone 
use (women only), all of which were updated from 
follow­up questionnaires. We additionally adjusted 
for baseline body mass index, hypertension, and 
hypercholesterolemia in both men and women. We 
used the cumulative average of dietary intakes from 
baseline to the censoring events to best represent long 
term diet and minimize within­person variation,23 
and we stopped updating dietary information after 
self reported diagnosis of intermediate outcomes, 
including type 2 diabetes, cardiovascular disease, 
and cancer. We modelled dairy intakes as categorical 
variables, and tested for trend by modelling the 
median value within each category as a continuous 
variable. 
All analyses were performed separately in each 
cohort, and then pooled to obtain the overall effect 
using a fixed effect model. We used random effects 
models if significant heterogeneity across cohorts was 
found. Statistical heterogeneity across studies was 
assessed by Cochrane Q test, with P<0.1 indicating 
significant heterogeneity between studies.30 We 
examined dose­response associations of dairy intake 
with risk of mortality by pooling individual level 
data in the three cohorts. We used restricted cubic 
splines with three knots to flexibly model the non­
linear association. To test for a potential non­linear 
association between dairy consumption and risk of 
mortality, we used a likelihood ratio test to compare 
the model with cubic spline terms to the model with 
a linear term of dairy consumption, with P<0.05 
denoting significant non­linearity. A significant P value 
for non­linearity indicated that the cubic spline model 
fitted the data better; therefore, we further tested for 
overall significance of curve using a likelihood ratio 
test by comparing the model with cubic spline terms 
to the model only with intercept. Otherwise, a non­
significant P value for non­linearity indicated that the 
linear model fitted the data better. 
Stratified analyses were conducted according to 
development of cardiovascular disease or cancer, 
cardiovascular drug treatment use, follow­up time 
(≤14 years or >14 years), calendar year (≤2000 or 
>2000), body mass index (≤25 or >25), age (≤75 or 
>75), smoking status (current smoker or never/past 
smoker), alternate healthy eating index (median score 
or less or more than median score), physical activity 
(median score or less or more than median score), total 
fat intake (median score or less or more than median 
score), calcium intake (median score or less or more 
than median score), and vitamin D intake (median 
score or less or more than median score). We treated 
the effect modifiers as time varying variables, and 
tested for potential effect modification by including an 
interaction term between the exposure and potential 
effect modifier in the Cox model and conducting a 
likelihood ratio test comparing the models with and 
without the interaction term.
We estimated the associations of substituting one 
serving per day of nuts and legumes, whole grain, 
poultry, or red and processed meat for total dairy 
by including both variables in continuous form in 
the same multivariate model. The difference in their 
regression coefficients were used to estimate the 
hazard ratios for the substitution and the covariance to 
estimate the 95% confidence intervals.31 All statistical 
tests were two sided at type I error rate of 0.05 and 
performed using SAS version 9.2 for UNIX (SAS 
Institute, Cary, NC). Because we tested multiple types 
of dairy foods and several death related outcomes, 
we conservatively corrected for multiple testing using 
Bonferroni correction and controlled for type I error 
rate at 0.05/60=0.001.
Patient and public involvement
No patients were involved in setting the research 
question or the outcome measures, nor were they 
involved in developing plans for design or imple­
mentation of the study. No patients were asked to 
advise on interpretation or writing up of results. 
There are no plans to disseminate the results of the 
research to study participants or the relevant patient 
community.
results
Our original analysis included 217 755 participants, 
of whom 74 805 were from the NHS, 93 348 from the 
NHSII, and 49 602 from the HPFS; 168 153 women 
and 49 602 men without cardiovascular disease 
or cancer at baseline. Table 1 shows the baseline 
characteristics of the participants by frequency of 
total dairy consumption. Those who consumed higher 
amounts of dairy foods drank less alcohol, were more 
likely to be physically active, were less likely to be 
current smokers, and had a slightly lower alternate 
healthy eating index.
During 29­32 years of follow­up, 51 438 deaths were 
documented in the three cohorts, including 12 143 
cardiovascular deaths and 15 120 cancer deaths. In 
an age adjusted model, dairy intake was positively 
associated with risk of total mortality in the NHSII 
and HPFS, but not NHS (table 2), which might be due 
to the different distribution of covariates according 
to dairy intake across the three cohorts as shown 
in table 1. However, after adjusting for covariates, 
dairy intake was positively associated with risk of 
mortality across the three cohorts (P for heterogeneity 
>0.1). Compared to the lowest category of total dairy 
consumption, the multivariable pooled hazard ratio 
for death was 1.07 (95% confidence interval 1.04 to 
1.10) for the highest category of dairy consumption (P 
for linear trend <0.001; table 2). The findings remained 
significant after correcting for multiple testing. We 
further investigated the associations of dairy intake 
with risk of mortality using a dose­response analysis. 
We saw a non­linear relation between total dairy intake 
and risk of total mortality (P for non­linearity <0.001; 
P for overall significance of the curve <0.001; P for 
linear association <0.001) and risk of cardiovascular 
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mortality (P=0.001; P=0.004; P=0.60; fig 1), such 
that moderate intake was associated with a slightly 
lower risk, whereas high intake was associated with 
an increased risk. Total dairy intake was associated 
with higher risk of cancer mortality in a linear fashion 
(P=0.10; P=0.04; P=0.048).
We further examined associations of subtypes 
of dairy foods with risk of total mortality and 
mortality due to cardiovascular disease and cancer 
(table 3, table S1). We categorized individual dairy 
products into four groups, and used different cutoff 
values for different types of dairy foods owing to 
low amounts of consumption for some specific 
dairy products. Intake of skimmed or low fat milk 
was associated with slightly higher risk of total 
mortality and cardiovascular mortality, and with a 
lower risk of colorectal cancer. Whole milk intake 
was significantly associated with higher risk of 
total mortality, cardiovascular mortality, and cancer 
mortality, including lung cancer, ovarian cancer, 
and prostate cancer. The associations of whole 
milk intake and risk of total mortality and cancer 
mortality remained significant after correcting for 
multiple testing (P for trend <0.001). Cheese and 
yogurt intake was not associated with risk of total 
or cause specific mortality. Further adjustment for 
smoking pack years and other dietary factors such 
as red meat did not appreciably change the results.
We estimated that substituting one serving per day 
of total dairy for nuts and legumes was associated 
with a 14% lower risk of total mortality (hazard ratio 
0.86, 95% confidence interval 0.78 to 0.95; fig 2). 
Substituting one dairy serving per day for whole 
grains was associated with an 11% lower risk of total 
mortality (0.89, 0.84 to 0.93). However, a substitution 
for red and processed meat was also associated with a 
5% higher risk of total mortality (1.05, 1.01 to 1.09).
In sensitivity analyses, we used time varying dairy 
intake updated every four years as exposure to provide 
more weight to the most recent diet. We found that 
dairy intake was not significantly associated with total 
mortality and mortality due to cancer and cardiovascular 
disease (table S2). To minimize reverse causation, we 
excluded participants who died during the first four 
years of follow­up, and results did not change (table 
S3). Significant interactions were found between dairy 
consumption and risk of mortality by body mass index 
(P value for interaction=0.03; table S4). A positive 
association was found among non­obese participants 
and no association was found among obese participants. 
We saw no significant differences in the associations 
between dairy consumption and risk of total mortality 
when stratified by disease status; cardiovascular drug 
treatment use; follow­up time; calendar year; age; 
smoking; diet quality; physical activity; and intakes of 
fat, calcium, and vitamin D (table S4).
discussion
Principal findings
The present analysis of three large cohort studies 
involving 217 755 participants and 51 438 deaths 
did not support an inverse association between dairy 
intake and mortality. The robustness of our findings 
was confirmed by using time varying intake of dairy 
that was updated every four years as the exposure, 
excluding deaths in the first four years of follow­up, 
and the results were unchanged. A dose­response 
analysis suggested that two servings per day of 
dairy consumption was associated with lowest total 
and cardiovascular disease mortality. Substitution 
analyses suggested that replacing dairy with nuts or 
legumes and whole grains could lower mortality risk, 
but replacing total dairy with red and processed meat 
could increase mortality risk.
table 1 | baseline characteristics of participants by fifths of total dairy consumption in the nurses’ Health study, nurses’ Health study ii, and Health 
Professionals Follow-up study. Data are mean values unless stated otherwise
characteristics
nurses’ Health study (1984) nurses’ Health study (1986)




















Dairy intake (servings/day)* 0.67 (0.28) 1.88 (0.16) 4.09 (1.15) 0.96 (0.37) 2.62 (0.24) 6.43 (2.52) 0.52 (0.24) 1.61 (0.15) 4.00 (1.29)
Age 49.9 50.4 50.5 36.8 36.3 35.7 54.1 54.2 54.6
Physical activity (MET-h/week) 12.9 14.7 15.4 23.4 24.1 25.5 19.5 20.9 21.3
Diet quality score† 48.1 48.1 46.6 49.7 48.8 47.6 54.0 53.1 50.7
Total energy intake (kcal/day)‡ 1449 1781 2101 1450 1723 2049 1656 1964 2384
Alcohol (g/day) 7.8 6.7 6.1 2.7 3.0 3.5 12.2 11.3 10.4
Body mass index 23.6 23.9 23.8 24.2 24.3 23.9 24.7 25.0 25.0
White ethnicity (No (%)) 19 677 (96) 13 110 (98) 14 955 (98) 15 174 (93) 14 518 (97) 28 017 (97) 9999 (92) 8611 (96) 10 608 (97)
Current smokers (No (%)) 6149 (30) 2809 (21) 3510 (23) 2447 (15) 1796 (12) 3466 (12) 1195 (11) 807 (9) 1203 (11)
Hypertension (No (%)) 1845 (9) 1070 (8) 1221 (8) 1142 (7) 1048 (7) 1733 (6) 2608 (24) 1973 (22) 2297 (21)
Hypercholesterolemia (No (%)) 820 (4) 401 (3) 458 (3) 2774 (17) 2245 (15) 3755 (13) 1739 (16) 1076 (12) 1094 (10)
Postmenopausal (No (%)) 9429 (46) 6421 (48) 7477 (49) 653 (4) 599 (4) 866 (3) NA NA NA
Postmenopausal hormone  
use (No (%))§ 2665 (13) 1873 (14) 2136 (14) 653 (4) 449 (3) 866 (3) NA NA NA
MET-h/week=metabolic equivalent hours per week; NA=not available. 
*Data are mean values and standard deviations.
†Alternate healthy eating index (range 0-100) was used, with a higher score indicating healthier diet.
‡1 kcal=4.18 kJ=0.00418 MJ.
§Percentage of current postmenopausal hormone use among total women.
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comparison with other studies
The association between dairy intake and risk of 
mortality has been extensively investigated. Some early 
studies showed positive associations between dairy 
intake and risk of mortality,10­12 while others showed 
inverse or null associations.13­17 By summarizing these 
studies, one meta­analysis showed that overall dairy 
intake was not associated with risk of mortality.18 19 
More prospective cohort studies with large sample 
sizes have since been conducted worldwide but with 
conflicting conclusions. For example, in two Swedish 
cohorts including 106 772 participants, dairy intake 
was associated with higher risk of mortality,11 but in 
a Danish cohort of 74 241 participants and a Dutch 
cohort of 34 409 participants, dairy intake was 
not associated with higher risk of mortality.32 33 In 
addition, in a Japanese cohort of 94 980 participants34 
and in the Prospective Urban Rural Epidemiology study 
table 2 | Hazard ratios of total, cardiovascular, and cancer mortality according to fifths of total dairy intake in the nurses’ Health study, nurses’ Health 
study ii, and Health Professionals Follow-up study
Frequency of dairy consumption* Hazard ratio  
(95% ci)† P for trendQ1 Q2 Q3 Q4 Q5
total mortality
Nurses’ Health Study
 No of deaths 4755 5021 5024 5347 5035 — — 
 Age adjusted 1.00 0.90 (0.87 to 0.94) 0.86 (0.83 to 0.90) 0.88 (0.84 to 0.91) 0.94 (0.91 to 0.98) 0.99 (0.97 to 1.00) 0.07
 Multivariate adjusted‡ 1.00 0.99 (0.95 to 1.03) 0.98 (0.94 to 1.02) 1.02 (0.97 to 1.06) 1.08 (1.03 to 1.13) 1.03 (1.02 to 1.05) <0.001
Nurses’ Health Study II
 No of deaths 624 521 549 484 518
 Age adjusted 1.00 0.84 (0.75 to 0.95) 0.93 (0.83 to 1.05) 0.90 (0.80 to 1.02) 1.12 (1.00 to 1.26) 1.03 (1.01 to 1.06) 0.008
 Multivariate adjusted‡ 1.00 0.96 (0.85 to 1.07) 1.02 (0.91 to 1.15) 1.02 (0.90 to 1.15) 1.16 (1.02 to 1.32) 1.04 (1.01 to 1.06) 0.01
Health Professionals Follow-up Study
 No of deaths 3969 4260 4806 5264 5261 — — 
 Age adjusted 1.00 0.96 (0.92 to 1.00) 0.97 (0.93 to 1.01) 0.99 (0.95 to 1.03) 1.03 (0.99 to 1.07) 1.02 (1.01 to 1.03) 0.005
 Multivariate adjusted‡ 1.00 0.98 (0.94 to 1.03) 1.02 (0.97 to 1.06) 1.03 (0.98 to 1.07) 1.05 (1.00 to 1.10) 1.02 (1.01 to 1.03) 0.006
Pooled analysis
 Age adjusted 1.00 0.92 (0.90 to 0.95) 0.91 (0.89 to 0.94) 0.93 (0.90 to 0.95) 0.99 (0.96 to 1.02) 1.01 (1.00 to 1.02) 0.10
 Multivariate adjusted‡ 1.00 0.98 (0.96 to 1.01) 1.00 (0.97 to 1.03) 1.02 (0.99 to 1.05) 1.07 (1.04 to 1.10) 1.03 (1.02 to 1.04) <0.001
cardiovascular mortality 
Nurses’ Health Study
 No of deaths 902 896 842 885 893 — —
 Age adjusted 1.00 0.86 (0.79 to 0.95) 0.78 (0.71 to 0.86) 0.78 (0.71 to 0.86) 0.88 (0.80 to 0.96) 0.96 (0.93 to 0.99) 0.01
 Multivariate adjusted‡ 1.00 0.97 (0.88 to 1.06) 0.91 (0.82 to 1.00) 0.94 (0.85 to 1.04) 1.04 (0.94 to 1.16) 1.02 (0.98 to 1.05) 0.34
Nurses’ Health Study II
 No of deaths 59 46 47 52 54 — — 
 Age adjusted 1.00 0.79 (0.54 to 1.17) 0.85 (0.58 to 1.24) 1.01 (0.69 to 1.47) 1.18 (0.81 to 1.71) 1.06 (0.98 to 1.15) 0.15
 Multivariate adjusted‡ 1.00 0.88 (0.61 to 1.27) 0.93 (0.63 to 1.37) 1.01 (0.67 to 1.51) 1.22 (0.81 to 1.83) 1.06 (0.97 to 1.15) 0.22
Health Professionals Follow-up Study
 No of deaths 1293 1358 1565 1616 1635 — — 
 Age adjusted 1.00 0.95 (0.88 to 1.02) 0.98 (0.91 to 1.05) 0.93 (0.87 to 1.01) 0.96 (0.89 to 1.03) 0.99 (0.97 to 1.01) 0.38
 Multivariate adjusted‡ 1.00 0.97 (0.90 to 1.05) 1.01 (0.94 to 1.09) 0.96 (0.89 to 1.04) 0.99 (0.91 to 1.08) 1.00 (0.97 to 1.02) 0.88
Pooled analysis
 Age adjusted 1.00 0.91 (0.86 to 0.96) 0.89 (0.84 to 0.95) 0.88 (0.83 to 0.93) 0.93 (0.88 to 0.99) 0.98 (0.97 to 1.00) 0.08
 Multivariate adjusted‡ 1.00 0.97 (0.91 to 1.03) 0.97 (0.92 to 1.03) 0.96 (0.90 to 1.02) 1.02 (0.95 to 1.08) 1.00 (0.99 to 1.03) 0.49
cancer mortality 
Nurses’ Health Study
 No of deaths 1557 1497 1514 1579 1494 — — 
 Age adjusted 1.00 0.86 (0.80 to 0.93) 0.84 (0.78 to 0.90) 0.85 (0.79 to 0.91) 0.88 (0.82 to 0.94) 0.97 (0.94 to 0.99) 0.004
 Multivariate adjusted‡ 1.00 0.95 (0.88 to 1.02) 0.96 (0.90 to 1.04) 0.99 (0.92 to 1.07) 1.02 (0.94 to 1.10) 1.02 (0.99 to 1.04) 0.29
Nurses’ Health Study II
 No of deaths 253 221 248 208 227 — — 
 Age adjusted 1.00 0.88 (0.74 to 1.06) 1.03 (0.87 to 1.23) 0.94 (0.79 to 1.14) 1.20 (1.00 to 1.43) 1.05 (1.01 to 1.09) 0.02
 Multivariate adjusted‡ 1.00 0.86 (0.71 to 1.03) 1.06 (0.89 to 1.27) 1.04 (0.86 to 1.26) 1.20 (0.98 to 1.47) 1.06 (1.01 to 1.10) 0.01
Health Professionals Follow-up Study
 No of deaths 1115 1140 1262 1424 1381 — — 
 Age adjusted 1.00 0.95 (0.88 to 1.03) 0.98 (0.90 to 1.06) 1.05 (0.97 to 1.13) 1.04 (0.96 to 1.13) 1.03 (1.00 to 1.05) 0.04
 Multivariate adjusted‡ 1.00 0.97 (0.89 to 1.05) 1.02 (0.94 to 1.11) 1.09 (1.00 to 1.18) 1.06 (0.97 to 1.15) 1.03 (1.00 to 1.06) 0.05
Pooled analysis
 Age adjusted 1.00 0.90 (0.85 to 0.95) 0.91 (0.86 to 0.96) 0.93 (0.89 to 0.98) 0.96 (0.92 to 1.01) 1.00 (0.99 to 1.02) 0.66
 Multivariate adjusted‡ 1.00 0.95 (0.90 to 1.00) 1.00 (0.94 to 1.05) 1.04 (0.98 to 1.09) 1.05 (0.99 to 1.11) 1.03 (1.01 to 1.05) 0.003
*Mean dairy intake for each fifth is: 0.8 servings/day for Q1, 1.5 servings/day for Q2, 2.0 servings/day for Q3, 2.8 servings/day for Q4, and 4.2 servings/day for Q5.
†Per increment of 1 serving/day of dairy.
‡Multivariable adjusted model was further adjusted for family history of cancer (yes, no), family history of cardiovascular disease (yes, no), baseline disease status (hypertension, 
hypercholesterolemia), baseline body mass index (<20.9, 21.0-22.9, 23.0-24.9, 25.0-29.9, 30.0-34.9, ≥35.0), physical activity (<3.0, 3.0-8.9, 9.0-17.9, 18.0-26.9, ≥27.0 metabolic equivalent 
hours per week), overall dietary pattern (alternate healthy eating index score, in fifths), total energy intake (fifths), smoking status (Nurses’ Health Study and Health Professionals Follow-up Study: 
never, former (categorized into 1-4, 5-14, 15-24, 25-34, 35-44, ≥45 cigarettes/day, or unknown), current (categorized in to 1-4, 5-14, 15-24, 25-34, 35-44, ≥45 cigarettes/day, or unknown), 
alcohol consumption (0, ≥0-5, ≥5-10, ≥10-15, ≥15 g/day), postmenopausal status (yes, no; women only), and current postmenopausal hormone use (yes, no; women only).
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including 136 384 participants from 21 countries and 
five continents, dairy intake was associated with lower 
risk of mortality.35 36
In our study, we found that total dairy intake was 
associated with slightly higher mortality, and the 
positive association remained even after correcting 
for multiple testing. The divergent findings across 
studies could be due to multiple reasons. For example, 
specific types of dairy foods varied across studies, the 
degree of residual confounding could have differed 
across studies because the covariates adjusted for 
were varied, and the effects of dairy foods could have 
depended on the nutritional quality of the background 
diet. However, the most important reason for the 
inconsistent findings could be the varied amount of 
dairy intake across populations—northern European 
countries consume the largest amount of dairy pro­
ducts worldwide whereas Asian countries such as 
Japan and China consume the least amount owing to 
high prevalence of lactose intolerance.37 38
In our study, whole milk intake was associated with 
higher risk of cancer mortality, including ovarian cancer 
and prostate cancer mortality. The positive associations 
of whole milk intake and cancer remained significant 
after correcting for multiple testing. Previous studies 
also showed that whole milk intake was associated 
with higher risks of prostate and ovarian cancer.8 9 39 40 
The effects of milk consumption on plasma insulin­
like growth factor 1,41 42 which predicts higher risks 
of prostate and breast cancer,43 provides a plausible 
mechanism. Galactose, a lactose metabolite contained 
in milk, has been thought to increase risk of ovarian 
cancer, but no relation was seen in a pooled analysis.44
We also observed that whole milk intake was 
associated with higher risk of cardiovascular mortality. 
This finding could be explained by saturated fatty 
acids from whole milk affecting the blood lipid profile 
and promoting atherosclerosis. Results from short 
term intervention studies indicated that a diet higher 
in saturated fatty acids from whole milk and butter 
increased low density lipoprotein cholesterol when 
substituted for carbohydrates or unsaturated fatty 
acids.34 Furthermore, the Dietary Approaches to Stop 
Hypertension dietary pattern lowered systolic blood 
pressure, and the high content of low fat dairy products 
in that diet might have contributed to the effect.45 
Observational studies also showed that saturated fat 
intake was associated with higher risk of coronary 
heart disease,46 although the effects depended on 
the substitution of unsaturated fats.47 One cohort 
study found that the replacement of dairy fat with 
polyunsaturated fat was significantly associated with 
lower risk of cardiovascular disease.48 Moreover, whole 
milk could be a marker of unhealthy diet and lifestyle. 
Although we adjusted for a wide range of diet and 
lifestyle factors, residual confounding remains a 
possibility. However, further adjustment for smoking 
pack years and other dietary factors such as red meat 
did not appreciably change the results. As for skimmed 
or reduced fat milk, participants who developed 
hypertension, hypercholesterolemia, or cardiovascular 
disease could change to adopt a healthier lifestyle by 
consuming more skimmed or reduced milk instead of 
whole milk. Although we stopped updating dietary 
intakes after the development of cardiovascular 
disease and cancer, reverse causation could remain 
and potentially explain a slightly positive association 
observed between skim milk intake and risk of 







































































Fig 1 | Dose-response associations of total dairy intake with risks of total mortality 
and mortality due to cardiovascular disease and cancer, based on pooled analyses 
of cohorts from the nurses’ Health study, nurses’ Health study ii, and Health 
Professionals Follow-up study. Multivariable adjusted model was further adjusted for 
family history of cancer (yes, no), family history of cardiovascular disease (yes, no), 
baseline disease status (hypertension, hypercholesterolemia), baseline body mass 
index (<20.9, 21.0-22.9, 23.0-24.9, 25.0-29.9, 30.0-34.9, ≥35.0), physical activity 
(<3.0, 3.0-8.9, 9.0-17.9, 18.0-26.9, ≥27.0 metabolic equivalent hours per week), overall 
dietary pattern (alternate healthy eating index score, in fifths), total energy intake 
(fifths), smoking status (nurses’ Health study and Health Professionals Follow-up 
study: never, former (categorized into 1-4, 5-14, 15-24, 25-34, 35-44, ≥45 cigarettes/
day, or unknown), current (categorized in to 1-4, 5-14, 15-24, 25-34, 35-44, ≥45 
cigarettes/day, or unknown), alcohol consumption (0, ≥0-5, ≥5-10, ≥10-15, ≥15 g/day), 
postmenopausal status (yes, no; women only), and current postmenopausal hormone 
use (yes, no; women only)
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be the reason for non­significant association between 
time­varying dairy intake and risk of total mortality in 
the sensitivity analysis.
Our study found that intake of skimmed or low 
fat milk was associated with lower risk of colorectal 
cancer mortality, and calcium contained in dairy foods 
might have an anti­carcinogenic effect. In previous 
meta­analyses and pooled analyses, milk consumption 
was inversely associated with risk of colorectal cancer, 
possibly because of its high calcium content.5 49 50 
Many prospective cohort studies showed that calcium 
intake was associated with lower risk of colorectal 
cancer,40 51 52 and clinical trials also showed that 
calcium supplementation reduced the recurrence of 
table 3 | Hazard ratios of total mortality and mortality due to cardiovascular disease and cancer according to consumptions of dairy food subtypes, 
based on pooled analyses of cohorts from the nurses’ Health study, nurses’ Health study ii, and Health Professionals Follow-up study*†
Dairy intake (by serving category)
Hazard ratio (95% ci)‡ P for trendcategory 1 category 2 category 3 category 4
skimmed or low fat milk (serving categories: <1/week, 1-4/week, 4/week-1.5/day, ≥1.5/day)
Total mortality
 NHS 1.00 0.95 (0.92 to 0.99) 0.98 (0.94 to 1.02) 1.05 (1.01 to 1.10) 1.02 (1.01 to 1.03) <0.001
 NHSII 1.00 0.89 (0.80 to 1.00) 0.88 (0.78 to 0.98) 0.93 (0.82 to 1.06) 0.99 (0.97 to 1.02) 0.64
 HPFS 1.00 0.98 (0.94 to 1.01) 1.01 (0.97 to 1.05) 1.04 (1.00 to 1.09) 1.01 (1.00 to 1.02) 0.01
 Pooled analysis 1.00 0.96 (0.93 to 0.99) 0.99 (0.96 to 1.02) 1.04 (1.01 to 1.07) 1.01 (1.00 to 1.02) <0.001
Cardiovascular mortality
 NHS 1.00 1.02 (0.93 to 1.11) 0.97 (0.89 to 1.06) 1.07 (0.97 to 1.19) 1.01 (0.99 to 1.04) 0.22
 NHSII 1.00 0.81 (0.57 to 1.13) 0.79 (0.56 to 1.12) 0.79 (0.53 to 1.19) 0.96 (0.88 to 1.05) 0.39
 HPFS 1.00 0.97 (0.90 to 1.04) 1.05 (0.98 to 1.13) 1.05 (0.97 to 1.13) 1.01 (1.00 to 1.02) 0.10
 Pooled analysis 1.00 0.98 (0.93 to 1.04) 1.02 (0.96 to 1.07) 1.05 (0.99 to 1.12) 1.01 (1.00 to 1.02) 0.06
Cancer mortality
 NHS 1.00 0.97 (0.91 to 1.04) 0.99 (0.92 to 1.05) 1.04 (0.96 to 1.12) 1.01 (0.99 to 1.03) 0.19
 NHSII 1.00 1.04 (0.87 to 1.24) 1.00 (0.84 to 1.20) 1.06 (0.87 to 1.29) 1.01 (0.97 to 1.05) 0.70
 HPFS 1.00 0.97 (0.90 to 1.05) 0.99 (0.92 to 1.06) 1.00 (0.92 to 1.08) 1.00 (0.98 to 1.02) 0.83
 Pooled analysis 1.00 0.98 (0.93 to 1.03) 0.99 (0.94 to 1.04) 1.02 (0.97 to 1.08) 1.00 (0.99 to 1.02) 0.28
Whole milk (serving categories: <1/month, 1-3/month, 3/month-2/week, ≥2/week)
Total mortality
 NHS 1.00 1.01 (0.97 to 1.05) 1.03 (0.99 to 1.07) 1.15 (1.10 to 1.19) 1.13 (1.10 to 1.17) <0.001
 NHSII 1.00 0.99 (0.84 to 1.16) 1.10 (0.93 to 1.29) 1.26 (1.08 to 1.48) 1.28 (1.10 to 1.49) 0.002
 HPFS 1.00 1.00 (0.95 to 1.05) 1.01 (0.96 to 1.06) 1.11 (1.07 to 1.16) 1.09 (1.05 to 1.13) <0.001
 Pooled analysis 1.00 1.00 (0.97 to 1.04) 1.03 (0.99 to 1.06) 1.13 (1.10 to 1.17) 1.11 (1.09 to 1.14) <0.001
Cardiovascular mortality
 NHS 1.00 1.05 (0.95 to 1.16) 0.98 (0.89 to 1.09) 1.17 (1.07 to 1.28) 1.14 (1.05 to 1.24) 0.001
 NHSII 1.00 0.88 (0.52 to 1.49) 1.04 (0.61 to 1.76) 1.18 (0.71 to 1.94) 1.18 (0.73 to 1.91) 0.49
 HPFS 1.00 0.98 (0.90 to 1.07) 1.07 (0.98 to 1.17) 1.06 (0.98 to 1.14) 1.05 (0.98 to 1.12) 0.15
 Pooled analysis 1.00 1.01 (0.95 to 1.08) 1.03 (0.96 to 1.10) 1.10 (1.04 to 1.17) 1.09 (1.03 to 1.15) 0.001
Cancer mortality
 NHS 1.00 1.01 (0.94 to 1.09) 1.04 (0.96 to 1.12) 1.12 (1.05 to 1.21) 1.11 (1.04 to 1.19) <0.001
 NHSII 1.00 1.02 (0.80 to 1.32) 1.06 (0.82 to 1.37) 1.32 (1.03 to 1.70) 1.30 (1.03 to 1.65) 0.03
 HPFS 1.00 0.98 (0.89 to 1.07) 0.98 (0.89 to 1.08) 1.12 (1.03 to 1.22) 1.10 (1.02 to 1.17) 0.006
 Pooled analysis 1.00 1.00 (0.94 to 1.06) 1.02 (0.96 to 1.08) 1.13 (1.07 to 1.19) 1.11 (1.06 to 1.17) <0.001
cheese (serving categories: <1/week, 1-4/week, 4/week-1.5/day, ≥1.5/day)
Total mortality
 NHS 1.00 1.03 (0.98 to 1.08) 1.04 (0.98 to 1.09) 1.09 (1.00 to 1.18) 1.02 (1.00 to 1.04) 0.07
 NHSII 1.00 1.01 (0.88 to 1.14) 1.13 (0.98 to 1.31) 1.20 (0.96 to 1.51) 1.08 (1.02 to 1.14) 0.009
 HPFS 1.00 0.90 (0.87 to 0.94) 0.92 (0.88 to 0.96) 0.92 (0.85 to 0.99) 0.98 (0.96 to 1.00) 0.04
 Pooled analysis 1.00 0.95 (0.92 to 0.98) 0.97 (0.94 to 1.01) 1.00 (0.95 to 1.06) 1.00 (0.99 to 1.02) 0.69
Cardiovascular mortality
 NHS 1.00 1.05 (0.93 to 1.17) 1.05 (0.94 to 1.19) 1.15 (0.95 to 1.39) 1.03 (0.98 to 1.08) 0.23
 NHSII 1.00 0.86 (0.58 to 1.27) 1.41 (0.93 to 2.16) 1.40 (0.70 to 2.79) 1.23 (1.04 to 1.45) 0.01
 HPFS 1.00 0.90 (0.84 to 0.96) 0.91 (0.84 to 0.98) 0.86 (0.75 to 0.99) 0.96 (0.93 to 1.00) 0.05
 Pooled analysis 1.00 0.93 (0.88 to 0.99) 0.96 (0.90 to 1.02) 0.96 (0.86 to 1.08) 0.99 (0.96 to 1.03) 0.61
Cancer mortality
 NHS 1.00 0.99 (0.91 to 1.08) 1.05 (0.96 to 1.15) 1.13 (0.98 to 1.30) 1.05 (1.01 to 1.09) 0.01
 NHSII 1.00 0.96 (0.79 to 1.16) 1.02 (0.82 to 1.26) 1.09 (0.76 to 1.55) 1.04 (0.95 to 1.13) 0.41
 HPFS 1.00 0.96 (0.89 to 1.03) 0.98 (0.90 to 1.06) 0.91 (0.78 to 1.07) 0.98 (0.95 to 1.02) 0.39
 Pooled analysis 1.00 0.97 (0.92 to 1.02) 1.01 (0.95 to 1.07) 1.03 (0.93 to 1.14) 1.02 (0.99 to 1.05) 0.16
NHS=Nurses’ Health Study; NHSII=Nurses’ Health Study II; HPFS=Health Professionals Follow-up Study.
*Associations for yogurt not shown to avoid duplication with another study.
†Multivariable adjusted model was further adjusted for family history of cancer (yes, no), family history of cardiovascular disease (yes, no), baseline disease status (hypertension, 
hypercholesterolemia), baseline body mass index (<20.9, 21.0-22.9, 23.0-24.9, 25.0-29.9, 30.0-34.9, ≥35.0), physical activity (<3.0, 3.0-8.9, 9.0-17.9, 18.0-26.9, ≥27.0 metabolic equivalent 
hours per week), overall dietary pattern (alternate healthy eating index score, in fifths), total energy intake (fifths), smoking status (Nurses’ Health Study and Health Professionals Follow-up Study: 
never, former (categorized into 1-4, 5-14, 15-24, 25-34, 35-44, ≥45 cigarettes/day, or unknown), current (categorized in to 1-4, 5-14, 15-24, 25-34, 35-44, ≥45 cigarettes/day, or unknown), 
alcohol consumption (0, ≥0-5, ≥5-10, ≥10-15, ≥15 g/day), postmenopausal status (yes, no; women only), and current postmenopausal hormone use (yes, no; women only). Subtypes of dairy 
foods were adjusted for each other.
‡Per increment of 0.5 servings/day.
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colorectal adenoma.53 Animal studies showed that 
calcium can suppress colonic epithelial cell pro­
liferation, induce apoptosis in colonic epithelium cells, 
and inhibit mutations of the colonic k ras gene.54 55
Our finding that dairy intake was not associated 
with lower risk of mortality was also consistent with 
mendelian randomisation studies using lactase 
persistence genotype rs4988235 as the instrumental 
variable. Two studies conducted in a Danish popula­
tion of 97 811 participants found that the T allele of 
rs4988235 was not associated with lower risks of 
type 2 diabetes, total mortality, and mortality due to 
cardiovascular disease and cancer.56 57 Two studies 
conducted within the CHARGE consortium involving 
more than 171 000 participants showed that the T 
allele of rs4988235 was associated with slightly higher 
body mass index and systolic blood pressure, two 
important risk factors of mortality.58 59
We conducted substitution analyses to predict the 
effects of replacing dairy products with other foods 
on mortality. We found that replacing dairy with nuts 
or legumes, poultry, and whole grains was associated 
with lower mortality. However, replacing total dairy 
with red and processed meat was associated with 
increased mortality. These data suggest that dietary 
recommendations on dairy intake should consider 
healthier alternatives. Moreover, the health effects of 
dairy intake could depend on the background diet. 
For example, in populations with high carbohydrate 
intake and poor quality diets, dairy foods and other 
protein sources might add important nutritional value.
strengths and limitations of study
Our study has several strengths. Firstly, dairy intake 
was measured repeatedly in all three cohorts, and 
we calculated cumulative averages for dairy intake 
to minimize the random measurement error caused 
by within­person variation. Furthermore, we stopped 
updating dairy intake on the diagnosis of potential 
intermediate conditions, which minimized the poten­
tial for reverse causation due to change of lifestyle 
factors because of chronic diseases. Secondly, our 
study included 217 755 participants with 51 438 
deaths. The large sample size and number of deaths 
provided sufficient power for the analyses. 
Several limitations also need to be considered. 
Firstly, the NHS, NHSII, and HPFS are predominantly 
white healthcare professionals, which could limit the 
generalizability of the findings to other nationalities 
and races. However, their occupations are a distinct 
advantage that allows us to collect high quality data 
using self reported questionnaires and enhance the 
internal validity of the study by reducing confounding. 
Secondly, given the observational study design, we 
could not directly establish a causal relation between 
dairy intake and mortality.
Nuts and legumes for total dairy
  Total mortality
  Cardiovascular mortality
  Cancer mortality
Whole grains for total dairy
  Total mortality
  Cardiovascular mortality
  Cancer mortality
Poultry for total dairy
  Total mortality
  Cardiovascular mortality
  Cancer mortality
Red meat and processed meat for total dairy
  Total mortality
  Cardiovascular mortality
  Cancer mortality
0.7 0.8 0.9 1.1 1.21.0 1.3
Hazard ratio for
mortality (95% CI)
Fig 2 | Hazard ratios for total mortality and mortality due to cardiovascular disease and cancer associated with 
replacement of total dairy with other foods in the nurses’ Health study, nurses’ Health study ii, and Health 
Professionals Follow-up study. error bars=95% confidence intervals. Multivariable adjusted model was further 
adjusted for family history of cancer (yes, no), family history of cardiovascular disease (yes, no), baseline disease 
status (hypertension, hypercholesterolemia), baseline body mass index (<20.9, 21.0-22.9, 23.0-24.9, 25.0-29.9, 
30.0-34.9, ≥35.0), physical activity (<3.0, 3.0-8.9, 9.0-17.9, 18.0-26.9, ≥27.0 metabolic equivalent hours per week), 
overall dietary pattern (alternate healthy eating index score, in fifths), total energy intake (fifths), smoking status 
(nurses’ Health study and Health Professionals Follow-up study: never, former (categorized into 1-4, 5-14, 15-24, 25-
34, 35-44, ≥45 cigarettes/day, or unknown), current (categorized in to 1-4, 5-14, 15-24, 25-34, 35-44, ≥45 cigarettes/
day, or unknown), alcohol consumption (0, ≥0-5, ≥5-10, ≥10-15, ≥15 g/day), postmenopausal status (yes, no; women 
only), and current postmenopausal hormone use (yes, no; women only)
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conclusions and policy implications
In conclusion, our data did not support an in­
verse association between high amount of dairy 
consumption and risk of mortality. A dose­response 
analysis suggested that two servings per day of dairy 
consumption was associated with lowest cardio­
vascular mortality, but higher intake was associated 
with a slightly higher mortality, especially cancer 
mortality. Substitution analyses suggested that the 
health effects of dairy products could depend on the 
comparison foods used to replace dairy.
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